JP2009513700A5 - - Google Patents

Download PDF

Info

Publication number
JP2009513700A5
JP2009513700A5 JP2008538915A JP2008538915A JP2009513700A5 JP 2009513700 A5 JP2009513700 A5 JP 2009513700A5 JP 2008538915 A JP2008538915 A JP 2008538915A JP 2008538915 A JP2008538915 A JP 2008538915A JP 2009513700 A5 JP2009513700 A5 JP 2009513700A5
Authority
JP
Japan
Prior art keywords
saturated
alkyl
partially unsaturated
heteroaryl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008538915A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513700A (ja
JP5137207B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/041251 external-priority patent/WO2007053345A1/en
Publication of JP2009513700A publication Critical patent/JP2009513700A/ja
Publication of JP2009513700A5 publication Critical patent/JP2009513700A5/ja
Application granted granted Critical
Publication of JP5137207B2 publication Critical patent/JP5137207B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008538915A 2005-11-01 2006-10-24 グルコキナーゼ活性化因子 Expired - Fee Related JP5137207B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73203705P 2005-11-01 2005-11-01
US60/732,037 2005-11-01
PCT/US2006/041251 WO2007053345A1 (en) 2005-11-01 2006-10-24 Glucokinase activators

Publications (3)

Publication Number Publication Date
JP2009513700A JP2009513700A (ja) 2009-04-02
JP2009513700A5 true JP2009513700A5 (https=) 2009-10-22
JP5137207B2 JP5137207B2 (ja) 2013-02-06

Family

ID=37685330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008538915A Expired - Fee Related JP5137207B2 (ja) 2005-11-01 2006-10-24 グルコキナーゼ活性化因子

Country Status (9)

Country Link
US (1) US8933077B2 (https=)
EP (1) EP1948652B1 (https=)
JP (1) JP5137207B2 (https=)
AT (1) ATE521608T1 (https=)
AU (1) AU2006309173B2 (https=)
CA (1) CA2628274A1 (https=)
ES (1) ES2372540T3 (https=)
NZ (1) NZ567858A (https=)
WO (1) WO2007053345A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1785420A1 (en) * 2005-11-14 2007-05-16 4Sc Ag Thiazole analogues and uses thereof
EP2061767B1 (de) 2006-08-08 2014-12-17 Sanofi Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
CA2681695A1 (en) * 2007-03-23 2008-10-02 Array Biopharma Inc. 2-aminopyridine analogs as glucokinase activators
WO2009022179A2 (en) * 2007-08-14 2009-02-19 Astrazeneca Ab Glucokinase activators in the treatment of osteoarthritis
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP2573087A1 (en) 2007-09-21 2013-03-27 Array Biopharma, Inc. Pyridin-2-yl-amino-1,2,4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
BRPI0818658A2 (pt) 2007-10-09 2015-04-14 Merck Patent Ges Mit Beschränkter Haftung Derivados de piridina úteis como ativadores de glicoquinase
KR101133772B1 (ko) 2007-12-20 2012-04-24 주식회사 엘지생명과학 글루코키나아제 활성화제 및 이를 활성성분으로 함유하는 약제학적 조성물
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
EP2408769A1 (en) * 2009-03-17 2012-01-25 Glaxo Group Limited Pyrimidine derivatives used as itk inhibitors
CN102639537B (zh) * 2009-07-10 2015-07-22 拜耳知识产权有限责任公司 吲唑基取代的二氢异*唑并吡啶及其使用方法
KR20120060207A (ko) 2009-08-26 2012-06-11 사노피 신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
CN102959076B (zh) 2010-03-31 2015-09-16 斯克里普斯研究所 重编程细胞
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
JPWO2012121314A1 (ja) 2011-03-09 2014-07-17 第一三共株式会社 ジピリジルアミン誘導体
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2804605A4 (en) * 2012-01-20 2015-07-08 Acucela Inc SUBSTITUTED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES
CA2877026A1 (en) 2012-05-18 2013-11-21 Amgen Inc. Method for the preparation of thiadiazoles
WO2019084529A1 (en) * 2017-10-29 2019-05-02 China Medical University ADAM9 INHIBITORS AND USES THEREOF
AU2019318209B2 (en) 2018-08-10 2025-09-25 Diapin Therapeutics, Llc Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
EP1169038B9 (en) 1999-04-15 2013-07-10 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
AU779908B2 (en) * 1999-09-10 2005-02-17 Merck & Co., Inc. Tyrosine kinase inhibitors
US6989385B2 (en) * 2000-12-21 2006-01-24 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
GB0226931D0 (en) * 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
NZ540791A (en) * 2003-02-13 2009-09-25 Banyu Pharma Co Ltd Novel 2-pyridinecarboxamide derivatives
US7687502B2 (en) * 2004-03-23 2010-03-30 Banyu Pharmaceutical Co., Ltd. Substituted quinazoline or pyridopyrimidine derivative

Similar Documents

Publication Publication Date Title
JP2009513700A5 (https=)
CA2917267C (en) Cyanotriazole compounds
EP2247586B1 (en) 2-aza-bicyclo[2.2.1]heptane derivatives
AU2007351498B2 (en) Organic compounds
KR101178747B1 (ko) 프로톤 펌프 저해제
CN102171204B (zh) 8位取代异喹啉衍生物及其用途
JP5040656B2 (ja) トリアリールカルボン酸誘導体
PT1910348T (pt) Compostos de benzotiazol e azabenzotiazol úteis como inibidores de quinases
JP2009524670A5 (https=)
BG107284A (bg) Заместени пиролопиридинонови производни полезни като инхибитори на фосфодиестераза
JP2015503529A5 (https=)
JP2013507355A (ja) キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物
CZ20023199A3 (cs) Modulátory receptoru adenosinu
CN103124730A (zh) 杂环炔苯类化合物及其药用组合物和应用
TW200819443A (en) An imidazole derivative
WO1999061436A1 (en) Heterocyclic indole derivatives and mono- or diazaindole derivatives
CN109153649A (zh) 烟碱乙酰胆碱受体的变构调节剂
CN101784276A (zh) 化合物在用于制备抗结核药剂中的用途
JP6559699B2 (ja) 置換含窒素複素環誘導体、それを含む医薬組成物及びその抗腫瘍性の適用
FR2911139A1 (fr) Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
CA2251681A1 (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
HRP20040874A2 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
KR20250121546A (ko) Gpr17 조절제 및 이의 용도
JP2001506666A (ja) イミダゾピリダジン
CN112469714A (zh) 作为端锚聚合酶抑制剂的1,2,4-三唑衍生物